Morgan Stanley: The AI capital expenditure cycle remains robust; recommends "maximum overweight" in global equities
Morgan Stanley strategists recommend taking a “max overweight” position on global equities, citing their belief that the AI capital expenditure cycle remains intact, which will drive continued economic and earnings growth into next year.
According to news from Zhitong Finance APP, Morgan Stanley strategists recommend adopting a "max overweight" position on global stocks, citing their belief that the AI capital expenditure cycle remains intact, which will drive continued economic and profit growth into next year. The bank maintains an "overweight" rating on U.S. stocks, while upgrading Japanese and European stocks to "overweight" and assigning an "equal weight" rating to emerging markets. Morgan Stanley also raised its S&P 500 target, implying a 15% upside potential.
Embracing Risk, Bullish on Global Stocks
Strategists, including Serena Tang, wrote in a November 15 report: "As risk assets become cheaper, we are embracing risk." "Within global equities, the story is spreading outward from mega-scale cloud providers, and 2027 will increasingly be about the returns of AI adopters."
The bank also forecasts a mild rebound in the U.S. dollar, and prefers investment-grade corporate bonds and gold.
This investment bank's optimistic outlook on the stock market is noteworthy as the U.S. midterm elections and persistent inflation have reignited doubts in the market about the monetization capability of the AI industry, leading to renewed volatility in global markets. The MSCI ACWI Index has fallen more than 4% from its August peak, while the benchmark chip stock index has dropped 23% since early October.
Morgan Stanley strategists stated that earnings growth for the MSCI ACWI could reach 13% next year, and valuation drag should ease or even reverse. They added that the index’s consensus forward price-to-earnings ratio stands at 15x, the lowest since 2023.
The strategists said: "Given our base case for global economic growth and the leverage of listed companies to long-term capital expenditure and innovation themes, the strong earnings growth trend may continue. With tighter liquidity conditions, valuation multiples for 2026 have dropped significantly—this may no longer be a headwind next year."
Morgan Stanley said it favors U.S. stocks with “pro-cyclical characteristics,” and also considers reflation one of the positive factors for Japanese equities. Based on valuations, the bank is more optimistic about Korean stocks than Taiwan stocks.
Views on Other Assets
The bank is also bullish on German and UK government bonds, as market pricing for Bank of England rate hikes exceeds the bank's own forecast, while pricing for the European Central Bank's policy easing in 2028 is less than expected.
In the U.S., the bank's strategists said that as they expect the Federal Reserve to raise rates two more times, the yield on 10-year U.S. Treasury bonds may rise to 5.05% in the first half of next year.
Strategists, including Matthew Hornbach, wrote in the same report: "As market pricing is skewed toward hawkish outcomes, we expect yields in most G10 countries to be below forward levels, especially in 2028, while yield curves will become steeper."
On Monday, as of press time, the Nikkei 225 Index fell 1.98% to 59,932.01, breaking below the 60,000-point threshold. The Korean KOSPI Index fell 2.78% to 5,143.49.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-T1 Energy’s stock price plummets due to plan to sell $100 million in shares

BUZZ-MiniMed shares rise as its tubeless insulin pump receives FDA approval
